FERRING B.V. v. MYLAN, INC. et al
Filing
71
ORDERED THAT THE FOLLOWING CLAIM CONSTRUCTION IS ADOPTED: THE CLAIM TERM "MODIFIED RELEASE MATERIAL" IS TO BE CONSTRUED TO MEAN "A MATERIAL THAT MODIFIES THE RELEASE OF THE ACTIVE PHARMACEUTICAL INGREDIENT." SIGNED BY HONORABLE ROBERT F. KELLY ON 11/25/2014. 11/25/2014 ENTERED AND COPIES E-MAILED.(sg, )
<![CDATA[
IN THE UNITED STATES DISTRICT COURT
FOR THE EASTERN DISTRICT OF PENNSYLVANIA
FERRING B.V.,
Plaintiff and
Counterclaim-Defendant,
v.
MYLAN PHARMACEUTICALS INC.,
Defendant and
Counterclaim-Plaintiff.
:
:
:
:
:
:
:
:
:
:
:
:
:
CIVIL ACTION
No. 13-5909
ORDER
AND NOW, this 25th day of November, 2014, it is hereby ORDERED that the
following claim construction is adopted:
The claim term “modified release material” is to be construed to mean “a
material that modifies the release of the active pharmaceutical ingredient.”
BY THE COURT:
/s/ Robert F. Kelly
ROBERT F. KELLY
SENIOR JUDGE
]]>
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?
